As to diseases, make a habit of two things — to help, or at least, to do no harm.

I do not believe there is a health professional on the planet that has not heard this quote from Hippocrates. It is as close to a postulate of medicine as anything I have come across.

WASHINGTON, DC—When VA Secretary Eric Shinseki took his post nearly two years ago, he learned that veterans lead the nation in homelessness, depression, substance abuse, and suicide.

Opinion poll:
Should VA direct more resources to prevent homelessness or to care for those already homeless? Please read the article about ending homelessness among Veterans and participate in the online poll.

WASHINGTON, DC— The Army Medical Communications for Combat Casualty Care (MC4) electronic medical record systems are being upgraded to help providers better document mild TBI patient data in theater.

WASHINGTON, DC—“Historically, it takes many years and lots of research money to go from the initial concept—an idea created in a lab—to the few of those trials that are successful and actually change clinical practice,” said Marc Blackman, MD.

WASHINGTON,DC—For the first time since federal research agencies began conducting research on Alzheimer’s disease (AD), there is a national plan designed to focus those efforts.

WASHINGTON, DC—The Air National Guard is lending its expertise when it comes to transporting severely injured servicemembers in the aeromedical evacuation system.

WASHINGTON, DC—Asking servicemembers and veteran patients about sleep can serve as a segue to conversations about other post-deployment issues that these patients might be experiencing, said Paula Domenici, PhD.

The Pharmacy Consultant to the Air Force Surgeon General advises Air Force Medical Service (AFMS) leadership and staff regarding pharmacy related issues.

BETHESDA, MD—Even drugs that have been on the market for years, sometimes decades, are not immune from reexamination and relabeling brought about by new scientific discoveries. In the field of pharmacogenomics especially, new opportunities are presenting themselves to use new science to improve drug safety and dosing protocols.

WASHINGTON, DC— Severe acute respiratory syndrome (SARS) swept across the globe in 2003 with a near 10% mortality rate. VA patients over the age of 65 were particularly vulnerable, and faced a 50% mortality rate.